Cargando…

Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study

BACKGROUND: Evaluating the routine of using control computer tomography (cCT) for determining the response status of muscle-invasive bladder cancer (MIBC) prior to final cycle of neoadjuvant chemotherapy (NAC) or induction chemotherapy (IC), in terms of predicting histopathological pTNM-staging and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogos, Haben, Eriksson, Elisabeth, Styrke, Johan, Sherif, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354331/
https://www.ncbi.nlm.nih.gov/pubmed/32676390
http://dx.doi.org/10.21037/tau-19-872
_version_ 1783558061956268032
author Mogos, Haben
Eriksson, Elisabeth
Styrke, Johan
Sherif, Amir
author_facet Mogos, Haben
Eriksson, Elisabeth
Styrke, Johan
Sherif, Amir
author_sort Mogos, Haben
collection PubMed
description BACKGROUND: Evaluating the routine of using control computer tomography (cCT) for determining the response status of muscle-invasive bladder cancer (MIBC) prior to final cycle of neoadjuvant chemotherapy (NAC) or induction chemotherapy (IC), in terms of predicting histopathological pTNM-staging and pathoanatomical responses/non-responses. Secondly, predicting two and three-year overall survival (OS). METHODS: Seventy-seven patients with localized MIBC (cT2-4aN0M0) and 3 patients with minimal nodal dissemination (cN1-2), undergoing NAC or IC and radical cystectomy (RC), the years 2006–2014 at Norrland university hospital in Umeå, Sweden. Baseline pre-cystectomy CTs and cCTs prior to final chemotherapy-cycle, were reviewed and underwent attempted RECIST-criteria categorization, into five response/non-response related subgroups (n=71). The diagnostic accuracy of cCT in comparison with pTNM was assessed using sensitivity, specificity, positive- and negative likelihood ratios. OS for 2 and 3 years was calculated, both in relation to histopathological pTNM-stages in all patients (n=80) and for the patients with cCT-evaluated categories (n=71). Multivariable analysis for OS, was performed in correlation to pTNM-stages firstly, and to radiological staging secondly. RESULTS: The sensitivity of cCT to predict non-responders according to pTMN was 64% and specificity 36%. The positive likelihood ratio=1 and the negative likelihood ratio =1. CT-evaluations couldn’t accurately predict pTNM-stages in terms of response/non-response. No statistically significant results were found in correlating cCTs with two and three-year OS. CONCLUSIONS: cCT prior to planned final preoperative chemotherapy-cycle in MIBC patients undergoing NAC or IC, has a poor correlation with pTNM and cannot predict pathoanatomical responses. Prediction of OS based on cCTs is unfeasible.
format Online
Article
Text
id pubmed-7354331
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-73543312020-07-15 Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study Mogos, Haben Eriksson, Elisabeth Styrke, Johan Sherif, Amir Transl Androl Urol Original Article BACKGROUND: Evaluating the routine of using control computer tomography (cCT) for determining the response status of muscle-invasive bladder cancer (MIBC) prior to final cycle of neoadjuvant chemotherapy (NAC) or induction chemotherapy (IC), in terms of predicting histopathological pTNM-staging and pathoanatomical responses/non-responses. Secondly, predicting two and three-year overall survival (OS). METHODS: Seventy-seven patients with localized MIBC (cT2-4aN0M0) and 3 patients with minimal nodal dissemination (cN1-2), undergoing NAC or IC and radical cystectomy (RC), the years 2006–2014 at Norrland university hospital in Umeå, Sweden. Baseline pre-cystectomy CTs and cCTs prior to final chemotherapy-cycle, were reviewed and underwent attempted RECIST-criteria categorization, into five response/non-response related subgroups (n=71). The diagnostic accuracy of cCT in comparison with pTNM was assessed using sensitivity, specificity, positive- and negative likelihood ratios. OS for 2 and 3 years was calculated, both in relation to histopathological pTNM-stages in all patients (n=80) and for the patients with cCT-evaluated categories (n=71). Multivariable analysis for OS, was performed in correlation to pTNM-stages firstly, and to radiological staging secondly. RESULTS: The sensitivity of cCT to predict non-responders according to pTMN was 64% and specificity 36%. The positive likelihood ratio=1 and the negative likelihood ratio =1. CT-evaluations couldn’t accurately predict pTNM-stages in terms of response/non-response. No statistically significant results were found in correlating cCTs with two and three-year OS. CONCLUSIONS: cCT prior to planned final preoperative chemotherapy-cycle in MIBC patients undergoing NAC or IC, has a poor correlation with pTNM and cannot predict pathoanatomical responses. Prediction of OS based on cCTs is unfeasible. AME Publishing Company 2020-06 /pmc/articles/PMC7354331/ /pubmed/32676390 http://dx.doi.org/10.21037/tau-19-872 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Mogos, Haben
Eriksson, Elisabeth
Styrke, Johan
Sherif, Amir
Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title_full Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title_fullStr Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title_full_unstemmed Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title_short Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
title_sort computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis—results of a single centre retrospective prognostic study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354331/
https://www.ncbi.nlm.nih.gov/pubmed/32676390
http://dx.doi.org/10.21037/tau-19-872
work_keys_str_mv AT mogoshaben computerizedtomographybeforethefinaltreatmentcycleofneoadjuvantchemotherapyorinductionchemotherapyinmuscleinvasiveurinarybladdercancercannotpredictpathoanatomicaloutcomesanddoesnotreflectprognosisresultsofasinglecentreretrospectiveprognosticstudy
AT erikssonelisabeth computerizedtomographybeforethefinaltreatmentcycleofneoadjuvantchemotherapyorinductionchemotherapyinmuscleinvasiveurinarybladdercancercannotpredictpathoanatomicaloutcomesanddoesnotreflectprognosisresultsofasinglecentreretrospectiveprognosticstudy
AT styrkejohan computerizedtomographybeforethefinaltreatmentcycleofneoadjuvantchemotherapyorinductionchemotherapyinmuscleinvasiveurinarybladdercancercannotpredictpathoanatomicaloutcomesanddoesnotreflectprognosisresultsofasinglecentreretrospectiveprognosticstudy
AT sherifamir computerizedtomographybeforethefinaltreatmentcycleofneoadjuvantchemotherapyorinductionchemotherapyinmuscleinvasiveurinarybladdercancercannotpredictpathoanatomicaloutcomesanddoesnotreflectprognosisresultsofasinglecentreretrospectiveprognosticstudy